Self-assembling nucleic acid nanostructures functionalized with aptamers

A Krissanaprasit, CM Key, S Pontula… - Chemical …, 2021 - ACS Publications
Researchers have worked for many decades to master the rules of biomolecular design that
would allow artificial biopolymer complexes to self-assemble and function similarly to the …

Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration

Z Zhou, X Liu, D Zhu, Y Wang, Z Zhang, X Zhou… - Advanced drug delivery …, 2017 - Elsevier
Gene therapy represents a promising cancer treatment featuring high efficacy and limited
side effects, but it is stymied by a lack of safe and efficient gene-delivery vectors. Cationic …

Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression

F Pi, DW Binzel, TJ Lee, Z Li, M Sun… - Nature …, 2018 - nature.com
Nanotechnology offers many benefits, and here we report an advantage of applying RNA
nanotechnology for directional control. The orientation of arrow-shaped RNA was altered to …

Advancement of the emerging field of RNA nanotechnology

D Jasinski, F Haque, DW Binzel, P Guo - ACS nano, 2017 - ACS Publications
The field of RNA nanotechnology has advanced rapidly during the past decade. A variety of
programmable RNA nanoparticles with defined shape, size, and stoichiometry have been …

RNA interference-based therapy and its delivery systems

X Chen, LS Mangala, C Rodriguez-Aguayo… - Cancer and Metastasis …, 2018 - Springer
RNA interference (RNAi) is considered a highly specific approach for gene silencing and
holds tremendous potential for treatment of various pathologic conditions such as …

Delivery of anti-miRNA for triple-negative breast cancer therapy using RNA nanoparticles targeting stem cell marker CD133

H Yin, G **
Z Zheng, Z Li, C Xu, B Guo, P Guo - Journal of Controlled Release, 2019 - Elsevier
Folate (FA) receptor is a cell surface glycoprotein overexpressed on many cancer cells. It is
a high affinity ligand for cancer cell targeting. However, delivery of siRNA directly through …

Opportunities, barriers, and a strategy for overcoming translational challenges to therapeutic nucleic acid nanotechnology

KA Afonin, MA Dobrovolskaia, G Church… - Therapeutic RNA …, 2021 - taylorfrancis.com
606Recent clinical successes using therapeutic nucleic acids (TNAs) have accelerated the
transition of nucleic acid nanotechnology toward therapeutic applications. Significant …

Structure and composition define immunorecognition of nucleic acid nanoparticles

E Hong, JR Halman, AB Shah… - Therapeutic RNA …, 2021 - taylorfrancis.com
912Nucleic acid nanoparticles (NANPs) have evolved as a new class of therapeutics with
the potential to detect and treat diseases. Despite tremendous advancements in NANP …